Personalized Medicines Market

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Personalized Medicines Market aims to provide a comprehensive presentation of the global market for Personalized Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines. Personalized Medicines Market contains market size and forecasts of Personalized Medicines in global, including the following market information:
Global Personalized Medicines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Personalized Medicines market was valued at US$ 266890 million in 2022 and is projected to reach US$ 532910 million by 2029, at a CAGR of 10.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.
We surveyed the Personalized Medicines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalized Medicines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Personalized Medicines Market Segment Percentages, by Type, 2022 (%)
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Global Personalized Medicines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Personalized Medicines Market Segment Percentages, by Application, 2022 (%)
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
Global Personalized Medicines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Personalized Medicines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Personalized Medicines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Personalized Medicines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Outline of Major Chapters:
Chapter 1: Introduces the definition of Personalized Medicines, market overview.
Chapter 2: Global Personalized Medicines market size in revenue.
Chapter 3: Detailed analysis of Personalized Medicines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Personalized Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.